Caffeic acid, tyrosol and p-coumaric acid are potent inhibitors of 5-S-cysteinyl-dopamine induced neurotoxicity
Abstract
Parkinson's disease is characterized by a progressive and selective loss of dopaminergic neurons in the substantia nigra. Recent investigations have shown that conjugates such as the 5-S-cysteinyl-dopamine, possess strong neurotoxicity and may contribute to the underlying progression of the disease pathology. Although the neuroprotective actions of flavonoids are well reported, that of hydroxycinnamates and other phenolic acids is less established. We show that the hydroxycinnamates caffeic acid and p-coumaric acid, the hydroxyphenethyl alcohol, tyrosol, and a Champagne wine extract rich in these components protect neurons against injury induced by 5-S-cysteinyl-dopamine in vitro. The protection induced by these polyphenols was equal to or greater than that observed for the flavonoids, (+)-catechin, (-)-epicatechin and quercetin. For example, p-coumaric acid evoked significantly more protection at 1muM (64.0+/-3.1%) than both (-)-epicatechin (46.0+/-4.1%, p<0.05) and (+)-catechin (13.1+/-3.0%, p<0.001) at the same concentration. These data indicate that hydroxycinnamates, phenolic acids and phenolic alcohol are also capable of inducing neuroprotective effects to a similar extent to that seen with flavonoids.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The fraction of phenolic compounds, consisting mainly of caffeic acid, quinic acid, and the chlorogenic acids family, is suggested to be the main compounds responsible for the antioxidant and anti-inflammatory properties of coffee ground extracts.
“It is suggested that the fraction of phenolic compounds, consisting mainly of caffeic acid (CA), quinic acid (QA), and the chlorogenic acids family, are the main compounds responsible for these properties [145,146,147,148,149,150,151].”
From Multi-Target Mechanisms of Phytochemicals in Alzheimer’s Disease: Effects on Oxidative Stress, Neuroinflammation and Protein Aggregation (2022) · cites this paper as [151]
Cites
Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies
Manach, C., Williamson, G., Morand, C., Scalbert, A., & Rémésy, C. (2005) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/81.1.230s · Cited by 4,219 · see citing works
Dietary Intake and Bioavailability of Polyphenols
Scalbert, A., & Williamson, G. (2000) · The Journal of Nutrition · doi:10.1093/jn/130.8.2073s · Cited by 3,658 · see citing works
Dietary polyphenols and the prevention of diseases
Scalbert, A., Manach, C., Morand, C., Rémésy, C., & Jiménez, L. (2005) · Critical Reviews in Food Science and Nutrition · doi:10.1080/1040869059096 · Cited by 2,999 · see citing works
Oxidative stress in Parkinson's disease
Jenner, P. (2003) · Annals of Neurology · doi:10.1002/ana.10483 · Cited by 2,053 · see citing works
Dietary phenolics: chemistry, bioavailability and effects on health
Crozier, A., Jaganath, I. B., & Clifford, M. N. (2009) · Natural Product Reports · doi:10.1039/b802662a · Cited by 2,002 · see citing works
Bioavailability and bioefficacy of polyphenols in humans. II. Review of 93 intervention studies
Williamson, G., & Manach, C. (2005) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/81.1.243s · Cited by 1,340 · see citing works
Walker, E. H., Pacold, M. E., Perišić, O., Stephens, L., Hawkins, P. T., Wymann, M. P., & Williams, R. L. (2000) · Molecular Cell · doi:10.1016/s1097-2765(05)00089-4 · Cited by 1,211 · see citing works
Alam, Z. I., Jenner, A., Daniel, S. E., Lees, A. J., Cairns, N., Marsden, C. D., Jenner, P., & Halliwell, B. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.69031196.x · Cited by 845 · see citing works
Polyphenols in foods are more complex than often thought
Cheynier, V. (2005) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/81.1.223s · Cited by 746 · see citing works
Dopamine covalently modifies and functionally inactivates parkin
LaVoie, M. J., Ostaszewski, B. L., Weihofen, A., Schlossmacher, M. G., & Selkoe, D. J. (2005) · Nature Medicine · doi:10.1038/nm1314 · Cited by 722 · see citing works
Intake of flavonoids and risk of dementia
Commenges, D., Scotet, V., Renaud, S., Jacqmin‐Gadda, H., Barberger‐Gateau, P., & Dartigues, J. (2000) · European Journal of Epidemiology · doi:10.1023/a:1007614613771 · Cited by 647 · see citing works
Flavonoid permeability across an in situ model of the blood–brain barrier
Youdim, K. A., Qaiser, M. Z., Begley, D. J., Rice-Evans, C. A., & Abbott, N. J. (2003) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2003.11.023 · Cited by 605 · see citing works
Antioxidant activities of flavonoids as bioactive components of food
Rice-Evans, C. A., & Miller, N. J. (1996) · Biochemical Society Transactions · doi:10.1042/bst0240790 · Cited by 584 · see citing works
Interaction between flavonoids and the blood–brain barrier: <i>in vitro</i> studies
Youdim, K. A., Dobbie, M. S., Kuhnle, G., Proteggente, A. R., Abbott, N. J., & Rice‐Evans, C. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01652.x · Cited by 578 · see citing works
The neuroprotective potential of flavonoids: a multiplicity of effects
Vauzour, D., Vafeiadou, K., Rodriguez‐Mateos, A., Rendeiro, C., & Spencer, J. P. E. (2008) · Genes & Nutrition · doi:10.1007/s12263-008-0091-4 · Cited by 561 · see citing works
Self-citationAgullo, G., Gamet‐Payrastre, L., Manenti, S., Viala, C., Rémésy, C., Chap, H., & Payrastre, B. (1997) · Biochemical Pharmacology · doi:10.1016/s0006-2952(97)82453-7 · Cited by 535 · see citing works
Resveratrol protects against global cerebral ischemic injury in gerbils
Wang, Q., Xu, J., Rottinghaus, G. E., Simonyi, Á., Lubahn, D. E., Sun, G. Y., & Sun, A. Y. (2002) · Brain Research · doi:10.1016/s0006-8993(02)03543-6 · Cited by 528 · see citing works
Invited Review Free radicals and the pathobiology of brain dopamine systems
Cadet, J. L., & Brannock, C. (1998) · Neurochemistry International · doi:10.1016/s0197-0186(97)00031-4 · Cited by 499 · see citing works
Flavanol monomer-induced changes to the human faecal microflora
Tzounis, X., Vulevic, J., Kuhnle, G., George, T. W., Leonczak, J., Gibson, G. R., Kwik-Uribe, C. L., & Spencer, J. P. E. (2007) · British Journal Of Nutrition · doi:10.1017/s0007114507853384 · Cited by 455 · see citing works
Self-citationWilliams, C. M., Mohsen, M. A. E., Vauzour, D., Rendeiro, C., Butler, L. T., Ellis, J. A., Whiteman, M., & Spencer, J. P. E. (2008) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2008.04.008 · Cited by 426 · see citing works
Self-citationSpencer, J. P. E., Jenner, P., Daniel, S. E., Lees, A. J., Marsden, D. C., & Halliwell, B. (1998) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1998.71052112.x · Cited by 373 · see citing works
Self-citationJoseph, J. A., Shukitt‐Hale, B., & Casadesús, G. (2005) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/81.1.313s · Cited by 368 · see citing works
Kainic Acid-Mediated Excitotoxicity as a Model for Neurodegeneration
Wang, Q., Yu, S. O., Simonyi, Á., Sun, G. Y., & Sun, A. Y. (2005) · Molecular Neurobiology · doi:10.1385/mn:31:1-3:003 · Cited by 365 · see citing works
Joseph, J. A., Arendash, G. W., Gordon, M. N., Diamond, D. M., Shukitt‐Hale, B., Morgan, D., & Denisova, N. A. (2003) · Nutritional Neuroscience · doi:10.1080/1028415031000111282 · Cited by 361 · see citing works
Spencer, J. P. E., Rice-Evans, C. A., & Williams, R. J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m305063200 · Cited by 350 · see citing works
Self-citationMAPK signaling in neurodegeneration: influences of flavonoids and of nitric oxide
Schroeter, H., BOYD, C., SPENCER, J., WILLIAMS, R., Cadenas, E., & Rice-Evans, C. A. (2002) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00075-1 · Cited by 338 · see citing works
Self-citationEsposito, E., Rotilio, D., DIMATTEO, V., Giulio, C. D., Cacchio, M., & Algeri, S. (2002) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00078-7 · Cited by 327 · see citing works
Bioavailability of phenolic acids
Lafay, S., & Gil‐Izquierdo, Á. (2007) · Phytochemistry Reviews · doi:10.1007/s11101-007-9077-x · Cited by 309 · see citing works
Bastianetto, S., Zheng, W., & Quirion, R. (2000) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703626 · Cited by 302 · see citing works
Andreasen, M. F., Kroon, P. A., Williamson, G., & García‐Conesa, M. (2001) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf010668c · Cited by 298 · see citing works
Fruit and vegetable phytochemicals: chemistry, nutritional value and stability
la Rosa, L. A. D., ́Álvarez-Parrilla, E., & González-Aguilar, G. A. (2009) · Andalas University Repository (Andalas University) · Cited by 294 · see citing works
Human fecal water content of phenolics: The extent of colonic exposure to aromatic compounds
Jenner, A. M., Rafter, J. J., & Halliwell, B. B. (2004) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2004.11.020 · Cited by 268 · see citing works
Biochemical and toxicological properties of the oxidation products of catecholamines
Bindoli, A., Rigobello, M. P., & Deeble, D. J. (1992) · Free Radical Biology and Medicine · doi:10.1016/0891-5849(92)90182-g · Cited by 264 · see citing works
Vauzour, D., Vafeiadou, K., Rice-Evans, C. A., Williams, R. J., & Spencer, J. P. E. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04841.x · Cited by 254 · see citing works
Self-citationGonthier, M., Rémésy, C., Scalbert, A., Cheynier, V., Souquet, J., Poutanen, K., & Aura, A. (2006) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2006.07.084 · Cited by 247 · see citing works
Estradiol protects mesencephalic dopaminergic neurons from oxidative stress-induced neuronal death
Sawada, H., Ibi, M., Kihara, T., Urushitani, M., Akaike, A., & Shimohama, S. (1998) · Journal of Neuroscience Research · doi:10.1002/(sici)1097-4547(19981201)54:5 · Cited by 246 · see citing works
Dietary Flavonoids as Potential Neuroprotectants
Youdim, K. A., Spencer, J. P. E., Schroeter, H., & Rice-Evans, C. A. (2002) · Biological Chemistry · doi:10.1515/bc.2002.052 · Cited by 210 · see citing works
Self-citationPerkinton, M. S., Sihra, T. S., & Williams, R. J. (1999) · Journal of Neuroscience · doi:10.1523/jneurosci.19-14-05861.1999 · Cited by 198 · see citing works
Reaction of oxidized dopamine with endogenous cysteine residues in the human dopamine transporter
Whitehead, R. E., Ferrer, J. V., Javitch, J. A., & Justice, J. B. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00125.x · Cited by 194 · see citing works
Kuhn, D. M., Arthur, R. E., Thomas, D. M., & Elferink, L. A. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0731309.x · Cited by 183 · see citing works
Sul, D., Kim, H.-S., Lee, D., Joo, S. S., Hwang, K. W., & Park, S. (2008) · Life Sciences · doi:10.1016/j.lfs.2008.12.001 · Cited by 158 · see citing works
Fornstedt, B., Rosengren, E., & Carlsson, A. (1986) · Neuropharmacology · doi:10.1016/0028-3908(86)90242-x · Cited by 155 · see citing works
Corona, G., Deiana, M., Incani, A., Vauzour, D., Dessì, M., & Spencer, J. P. E. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.08.049 · Cited by 153 · see citing works
Self-citationPezzella, A., d’Ischia, M., Napolitano, A., Misuraca, G., & Prota, G. (1997) · Journal of Medicinal Chemistry · doi:10.1021/jm970099t · Cited by 133 · see citing works
Zhang, F., & Dryhurst, G. (1994) · Journal of Medicinal Chemistry · doi:10.1021/jm00034a006 · Cited by 129 · see citing works
Phenolic Composition of Champagnes from Chardonnay and Pinot Noir Vintages
Chamkha, M., Cathala, B., Cheynier, V., et al. (2003) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf021105j · Cited by 128 · see citing works
Resveratrol Protects Against Neurotoxicity Induced by Kainic Acid
Wang, Q., Yu, S. O., Simonyi, Á., Rottinghaus, G. E., Sun, G. Y., & Sun, A. Y. (2004) · Neurochemical Research · doi:10.1007/s11064-004-6883-z · Cited by 123 · see citing works
Kerry, N. L., & Rice-Evans, C. A. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0730247.x · Cited by 114 · see citing works
Spencer, J. P. E., Whiteman, M., Jenner, P. G., & Halliwell, B. B. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.00808.x · Cited by 113 · see citing works
Self-citationAlcohol, ischemic heart disease, and the french paradox
Constant, J. (1997) · Clinical Cardiology · doi:10.1002/clc.4960200504 · Cited by 110 · see citing works
Li, H., & Dryhurst, G. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.69041530.x · Cited by 110 · see citing works
Neuroprotective effect of tyrosol on transient focal cerebral ischemia in rats
Bu, Y., Rho, S., Kim, J., et al. (2006) · Neuroscience Letters · doi:10.1016/j.neulet.2006.08.094 · Cited by 109 · see citing works
Evidence of postprandial absorption of olive oil phenols in humans.
Bonanome, A., Pagnan, A., Caruso, D., Toia, A., Xamin, A., Fedeli, E., Berra, B., Zamburlini, A., Ursini, F., & Galli, G. (2000) · PubMed · Cited by 100 · see citing works
Vauzour, D., Ravaioli, G. M., Vafeiadou, K., Rodriguez‐Mateos, A., Angeloni, C., & Spencer, J. P. E. (2008) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2008.03.011 · Cited by 96 · see citing works
Self-citationNeuroinflammation and its Modulation by Flavonoids
Vafeiadou, K., Vauzour, D., & Spencer, J. P. E. (2007) · Endocrine Metabolic & Immune Disorders - Drug Targets · doi:10.2174/187153007781662521 · Cited by 83 · see citing works
Self-citationShen, X.-M., & Dryhurst, G. (1996) · Chemical Research in Toxicology · doi:10.1021/tx960008f · Cited by 76 · see citing works
Meiergerd, S. M., & Schenk, J. O. (1994) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1994.62030998.x · Cited by 74 · see citing works
Nardini, M., Scaccini, C., Packer, L., et al. (2000) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/s0304-4165(00)00009-x · Cited by 69 · see citing works
ATP depletion inhibits glucocorticoid-induced thymocyte apoptosis
Stefanelli, C., Bonavita, F., Stanić, I., et al. (1997) · Biochemical Journal · doi:10.1042/bj3220909 · Cited by 59 · see citing works
Dietary antioxidants, peroxidation and cardiovascular risks.
Barbaste, M., Berke, B., Dumas, M., et al. (2002) · PubMed · Cited by 43 · see citing works
Inhibition of the formation of the neurotoxin 5-S-cysteinyl-dopamine by polyphenols
Vauzour, D., Vafeiadou, K., & Spencer, J. P. E. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.07.153 · Cited by 42 · see citing works
Self-citationVauzour, D., Houseman, E. J., George, T. W., Corona, G., Garnotel, R., Jackson, K. G., Sellier, C., Gillery, P., Kennedy, O. B., Lovegrove, J. A., et al. (2009) · British Journal Of Nutrition · doi:10.1017/s0007114509992959 · Cited by 39 · see citing works
Self-citationChampagne Wine Polyphenols Protect Primary Cortical Neurons against Peroxynitrite-Induced Injury
Vauzour, D., Vafeiadou, K., Corona, G., Pollard, S. E., Tzounis, X., & Spencer, J. P. E. (2007) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf063304z · Cited by 38 · see citing works
Self-citationCaffeic acid as biomarker of red wine intake
Simonetti, P., Gardana, C., & Pietta, P. (2001) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(01)35237-0 · Cited by 28 · see citing works
5-S-Cysteinyl-dopamine effect on the human dopaminergic neuroblastoma cell line SH-SY5Y
Mosca, L., Lendaro, E., D’Erme, M., et al. (2006) · Neurochemistry International · doi:10.1016/j.neuint.2006.01.023 · Cited by 27 · see citing works
Red wine consumption and brain aging
Bastianetto, S. (2002) · Nutrition · doi:10.1016/s0899-9007(01)00745-6 · Cited by 21 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Williams, R. J., & Spencer, J. P. E. (2012) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.09.010 · Cited by 448 · see citing works
Sharifi-Rad, J., Rapposelli, S., Sestito, S., Herrera-Bravo, J., Arancibia-Diaz, A., Salazar, L. A., Yeskaliyeva, B., Beyatli, A., Leyva-Gómez, G., González-Contreras, C., et al. (2022) · Journal of Personalized Medicine · doi:10.3390/jpm12091515 · Cited by 125 · see citing works
- Authors
- Vauzour, D., Corona, G., & Spencer, J. P. E.
- Affiliations
- University of Reading (GB)
- Corresponding author
- Spencer, Jeremy P.E.
- Venue
- Archives of Biochemistry and Biophysics
- Publisher
- Elsevier BV
- Published
- 2010-09
- Volume
- 501
- Issue
- 1
- Pages
- 106-111
- ISSN
- 0003-9861 (ISSN-L)
- OpenAlex
- W2082513203
- Cited by
- 166
- References
- 66
- Citations by year
- 2026: 1 · 2025: 7 · 2024: 6 · 2023: 11 · 2022: 16 · 2021: 8 · 2020: 13 · 2019: 15 · 2018: 8 · 2017: 12 · 2016: 16 · 2015: 7 · 2014: 11 · 2013: 8 · 2012: 17
- FWCI
- 6.41
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Archives of Biochemistry and Biophysics (publishedVersion)
- PubMed (publishedVersion)
- UEA Digital Repository (University of East Anglia) (acceptedVersion)
- Funders
- Medical Research Council (G0400278/NI02)
- Biotechnology and Biological Sciences Research Council (BB/F008953/1, BB/E023185/1, BB/G005702/1)
- European Union (FP7 FLAVIOLA)
- Topics
- Health Sciences › Medicine › Neurology › Parkinson's Disease Mechanisms and Treatments
- Health Sciences › Medicine › Biochemistry › Phytochemicals and Antioxidant Activities
- Life Sciences › Neuroscience › Neurology › Neurological Disorders and Treatments
- Keywords
- neurotoxicity, neuroprotection, Parkinson's disease, hydroxycinnamic acids, caffeic acid, p-coumaric acid, tyrosol, phenolic acids, flavonoids, catechins, quercetin, dopaminergic neurons, substantia nigra
- MeSH terms
- Animals, Caffeic Acids, Cells, Cultured, Coumaric Acids, Dopamine, Flavonoids, Neurons, Parkinson Disease, Phenylethyl Alcohol, Propionates, Wine, Neuroprotective Agents, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review